Please note patient recruitment and screening is now closed at this time. Thank you for your interest in participating in the Phase III Patidegib 2% topical gel clinical trial for the reduction of disease burden of basal cell carcinomas in Gorlin Syndrome sponsored by PellePharm. The participating sites in the US are listed below and […]
Dr. Sean Christensen, Assistant Professor of Dermatologic Surgery at Yale University School of Medicine, joined Julie Breneiser, president of the Gorlin Syndrome Alliance, patient, and mother of two affected children, for a live discussion about the Patidegib Clinical Trial involving a topical hedgehog inhibitor. If you were unable to join in on the conversation, you […]
The 2019 National Conference was a huge success!! With over 105 people registered, the hotel was filled with patients, caregivers, faculty, pharma execs, and staff. Nearly 60% of the those affected with Gorlin syndrome never attended a national conference before! You could really feel how the GSA touched the lives of our members in significant […]
PellePharm, Inc., a late clinical-stage biopharmaceutical company committed to targeting rare dermatologic conditions at their source, today announced it has dosed the first patient in a pivotal Phase 3 clinical trial of Patidegib Topical Gel, 2%, vs. vehicle gel in patients with Gorlin Syndrome. The Phase 3 study is intended to assess the safety and […]
Please note patient recruitment and screening is now closed at this time. Patient recruitment is starting for Pellepharm’s Phase III Patidegib Topical Gel 2%. The GSA is working closely with Pellepharm and maintains the most up-to-date list of clinical sites. Click here for more information about the trial and site locations.
News Alert – Review the Patidegib 2% Topical Gel Clinical Trial Posting Pellepharm’s Phase III Clinical Trial for Patidegib Topical Gel 2% just posted to ClinicalTrials.gov Patient recruitment for Pellepharm’s Phase 3 Patidegeb Topical Gel 2% is not currently active since the site locations cannot be published until contracts are signed and official. The BCCNS […]
“Fear of failure seems to be larger than the fear of fatigue.” My parents knew a few things at the beginning of my life. That sports were not exactly my strong suit and that I was born with Basal Cell Carcinoma Nevus Syndrome (BCCNS). The two, in my opinion, have been conquered together. Although I knew […]